{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:27:49Z","timestamp":1791444469540,"version":"4.3.3"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"\n Importance<\/jats:title>\n Given the favorable prognosis of papillary thyroid microcarcinoma (PTMC), treatment decisions increasingly rely on patient-reported outcomes (PROs), such as health-related quality of life (HRQOL). Comparative HRQOL data between active surveillance, thermal ablation, and surgery remain limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare HRQOL among adults with PTMC undergoing active surveillance, thermal ablation, or surgery to inform shared decision-making.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n Embase, MEDLINE via Ovid, Web of Science Core Collection, Cochrane Central Register of Controlled Trials, and the top 100 references of Google Scholar were searched from inception to June 17, 2025.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Eligible studies included adult patients with PTMC and compared at least 2 relevant interventions while reporting PROs. Studies restricted to noncomparative designs or non-PTMC populations were excluded. Two reviewers independently screened titles, abstracts, and full texts, resolving discrepancies with a third reviewer.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n This systematic review followed PRISMA 2020 and PRISMA-S guidelines; the meta-analysis adhered to MOOSE guidelines. Data were extracted by 1 reviewer and independently verified by a second. Study quality was assessed using established critical appraisal checklists. Random-effects models were applied to obtain mean differences with 95% CIs.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was domain-specific HRQOL (eg, voice problems, neuromuscular symptoms, psychological distress), as measured using the Thyroid Cancer Quality of Life (THYCA-QOL), Korean Thyroid-specific Quality of Life (KT-QOL), and other validated instruments.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 988 retrieved records, 13 studies comprising 5793 patients were included: 2356 underwent active surveillance, 242 received thermal ablation (211 radiofrequency, 31 laser), and 3195 underwent surgery (2350 lobectomy, 833 total thyroidectomy, 12 unspecified). Active surveillance was consistently associated with better PROs compared with surgery across thyroid-specific domains, including neuromuscular symptoms, voice problems, concentration issues, psychological distress, sympathetic complaints, feelings of being chilly, and scar-related concerns. Generic instruments (eg, 36-item Short Form Health Survey, version 2) supported these findings. Low-certainty evidence indicated that thermal ablation was associated with better HRQOL than surgery after 3 to 6 months, although these differences diminished by 12 months. Across studies, heterogeneity arose from differences in treatment strategies and comparators, outcome instruments and duration of follow-up.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This systematic review and meta-analysis found that patients whose PTMC was managed with active surveillance reported equal or better HRQOL than those undergoing surgery. These findings support the importance of incorporating PROs into shared decision-making for low-risk thyroid cancer.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoto.2025.4670","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:30:45Z","timestamp":1766766645000},"page":"154","source":"Crossref","is-referenced-by-count":4,"title":["Patient-Reported Outcomes Across Treatment Strategies in Papillary Thyroid Microcarcinoma"],"prefix":"10.1001","volume":"152","author":[{"given":"Sam P. J.","family":"van Dijk","sequence":"first","affiliation":[{"name":"Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Surgical Oncology and Gastrointestinal Surgery, Academic Center for Thyroid Disease, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M. K.","family":"Blanco","sequence":"additional","affiliation":[{"name":"Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Liu","family":"McMullin","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Scott","family":"Gazelle","sequence":"additional","affiliation":[{"name":"MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Jalali","sequence":"additional","affiliation":[{"name":"MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"},{"name":"Sloan School of Management, Massachusetts Institute of Technology, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagpreet","family":"Chhatwal","sequence":"additional","affiliation":[{"name":"MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajshri M.","family":"Gartland","sequence":"additional","affiliation":[{"name":"Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Husson","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology and Gastrointestinal Surgery, Academic Center for Thyroid Disease, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"},{"name":"Department of Medical Oncology, Netherlands Cancer Institute\u2013Antoni Van Leeuwenhoek, Amsterdam, the Netherlands"},{"name":"Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinin","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University of Maryland Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Shannon","family":"Swan","sequence":"additional","affiliation":[{"name":"MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa M.","family":"van Ginhoven","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology and Gastrointestinal Surgery, Academic Center for Thyroid Disease, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"ooi250082r1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the United States.","volume":"140","author":"Davies","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"ooi250082r2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1089\/thy.2004.14.1056","article-title":"Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.","volume":"14","author":"Leenhardt","year":"2004","journal-title":"Thyroid"},{"issue":"8","key":"ooi250082r3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1089\/thy.2020.0845","article-title":"Active surveillance for papillary thyroid microcarcinoma in a population with restrictive diagnostic workup strategies.","volume":"31","author":"Loncar","year":"2021","journal-title":"Thyroid"},{"issue":"7","key":"ooi250082r4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis.","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med"},{"key":"ooi250082r5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2019.00010","article-title":"Survival in papillary thyroid microcarcinoma: a comparative analysis between the 7th and 8th versions of the AJCC\/UICC Staging System based on the SEER database.","volume":"10","author":"Yang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"ooi250082r6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00268-015-3300-5","article-title":"Quality of life in thyroid cancer is similar to that of other cancers with worse survival.","volume":"40","author":"Applewhite","year":"2016","journal-title":"World J Surg"},{"key":"ooi250082r7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijsu.2017.12.014","article-title":"Quality of life in differentiated thyroid cancer.","volume":"50","author":"McIntyre","year":"2018","journal-title":"Int J Surg"},{"issue":"5","key":"ooi250082r8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/SLA.0000000000005129","article-title":"Impact of permanent post-thyroidectomy hypoparathyroidism on self-evaluation of quality of life and voice: results from the National QoL-Hypopara Study.","volume":"274","author":"Frey","year":"2021","journal-title":"Ann Surg"},{"issue":"6","key":"ooi250082r9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1210\/clinem\/dgad748","article-title":"Longitudinal changes in quality of life before and after thyroidectomy in patients with differentiated thyroid cancer.","volume":"109","author":"Kim","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ooi250082r10","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-23-0067","article-title":"2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.","volume":"12","author":"Durante","year":"2023","journal-title":"Eur Thyroid J"},{"issue":"8","key":"ooi250082r11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"4","key":"ooi250082r12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamaoto.2021.4381","article-title":"Assessment of radiofrequency ablation for papillary microcarcinoma of the thyroid: a systematic review and meta-analysis.","volume":"148","author":"van Dijk","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"4","key":"ooi250082r13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5195\/jmla.2018.283","article-title":"A systematic approach to searching: an efficient and complete method to develop literature searches.","volume":"106","author":"Bramer","year":"2018","journal-title":"J Med Libr Assoc"},{"key":"ooi250082r15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"ooi250082r16","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/s41467-025-57627-7","article-title":"A multicenter cohort study of thyroidectomy-related decision regret in patients with low-risk papillary thyroid microcarcinoma.","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"ooi250082r17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1398208","article-title":"Comparison between thermal ablation and surgery in low risk papillary thyroid carcinoma: a prospective study.","volume":"15","author":"Gong","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"ooi250082r18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/02656736.2021.1916625","article-title":"Radiofrequency ablation versus total thyroidectomy in patients with papillary thyroid microcarcinoma located in the isthmus: a retrospective cohort study.","volume":"38","author":"Song","year":"2021","journal-title":"Int J Hyperthermia"},{"issue":"4","key":"ooi250082r19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis.","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid Based Healthc"},{"issue":"7","key":"ooi250082r20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1089\/thy.2018.0711","article-title":"Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy: a cross-sectional study.","volume":"29","author":"Jeon","year":"2019","journal-title":"Thyroid"},{"issue":"5","key":"ooi250082r21","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00268-022-06786-5","article-title":"Patient-reported outcomes in patients with low-risk papillary thyroid carcinoma: cross-sectional study to compare active surveillance and immediate surgery.","volume":"47","author":"Kazusaka","year":"2023","journal-title":"World J Surg"},{"issue":"11","key":"ooi250082r22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1089\/thy.2024.0264","article-title":"Comparison of patient-reported outcomes between active surveillance and immediate lobectomy in patients with low-risk papillary thyroid microcarcinoma: initial findings from the KoMPASS cohort.","volume":"34","author":"Kim","year":"2024","journal-title":"Thyroid"},{"issue":"8","key":"ooi250082r23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1089\/thy.2018.0624","article-title":"Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients: active surveillance or immediate surgery (interim analysis of MAeSTro).","volume":"29","author":"Kong","year":"2019","journal-title":"Thyroid"},{"issue":"6","key":"ooi250082r24","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/cam4.3747","article-title":"The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: a cross-sectional study.","volume":"10","author":"Lan","year":"2021","journal-title":"Cancer Med"},{"key":"ooi250082r25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fendo.2020.00249","article-title":"Quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation or surgery: a comparative study.","volume":"11","author":"Lan","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"ooi250082r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.04.016","article-title":"Active surveillance versus immediate surgery: a comparison of clinical and quality of life outcomes among patients with highly suspicious thyroid nodules 1 cm or smaller in China.","volume":"49","author":"Liu","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"ooi250082r27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/clinem\/dgaa889","article-title":"Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma.","volume":"106","author":"Moon","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"ooi250082r28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.4158\/EP-2020-0201","article-title":"Quality of life in patients with low-risk papillary thyroid microcarcinoma: active surveillance versus immediate surgery.","volume":"26","author":"Nakamura","year":"2020","journal-title":"Endocr Pract"},{"issue":"5","key":"ooi250082r29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/thy.2019.0420","article-title":"Patients\u2019 view on the management of papillary thyroid microcarcinoma: active surveillance or surgery.","volume":"30","author":"Yoshida","year":"2020","journal-title":"Thyroid"},{"issue":"11","key":"ooi250082r30","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1001\/jamaoncol.2022.3875","article-title":"Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial.","volume":"8","author":"Ho","year":"2022","journal-title":"JAMA Oncol"},{"issue":"15","key":"ooi250082r31","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer.","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"ooi250082r32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","article-title":"Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients.","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"issue":"4","key":"ooi250082r33","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300018","article-title":"Patient-reported outcomes 12 years after localized prostate cancer treatment.","volume":"2","author":"Donovan","year":"2023","journal-title":"NEJM Evid"},{"issue":"3","key":"ooi250082r34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamaoncol.2024.6556","article-title":"Patient-reported outcomes for low-risk ductal carcinoma in situ: a secondary analysis of the COMET randomized clinical trial.","volume":"11","author":"Partridge","year":"2025","journal-title":"JAMA Oncol"},{"issue":"1","key":"ooi250082r35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.","volume":"29","author":"Cocks","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"ooi250082r37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1089\/thy.2024.0396","article-title":"The cancer-specific health economic measure QLU-C10D is valid and responsive for assessing health utility in patients with thyroid cancer.","volume":"34","author":"Pilz","year":"2024","journal-title":"Thyroid"},{"issue":"1","key":"ooi250082r38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamasurg.2023.5202","article-title":"Long-term outcomes and risk factors of radiofrequency ablation for T1N0M0 papillary thyroid carcinoma.","volume":"159","author":"Li","year":"2024","journal-title":"JAMA Surg"},{"issue":"1","key":"ooi250082r39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12885-021-08230-8","article-title":"Active surveillance for thyroid cancer: a qualitative study of barriers and facilitators to implementation.","volume":"21","author":"Jensen","year":"2021","journal-title":"BMC Cancer"},{"issue":"5","key":"ooi250082r40","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.21037\/gs-20-389","article-title":"Active surveillance for low-risk small papillary thyroid cancer in North American countries: past, present and future (bridging the gap between North American and Asian practices).","volume":"9","author":"Pusztaszeri","year":"2020","journal-title":"Gland Surg"},{"key":"ooi250082r14","volume-title":"Systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"key":"ooi250082r36","volume-title":"Thyroid Nodule Treatment Optimization: A Personalized Approach","author":"Cunningham","year":"2019"}],"container-title":["JAMA Otolaryngology\u2013Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2842670\/jamaotolaryngology_van_dijk_2025_oi_250082_1770606651.23233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:00:42Z","timestamp":1770912042000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2842670"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2025.4670","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}